Abeona Therapeutics (ABEO) had the highest return in 1991 by a US stock in the Biotechnology Industry, returning 433.5%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
CEL-SCI (CVM) | 1991 | 410% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Celldex Therapeutics (CLDX) | 1991 | 266.67% |
Amgen (AMGN) | 1991 | 256.47% |
GT Biopharma (GTBP) | 1991 | 240% |
Insmed (INSM) | 1991 | 121.21% |
Anixa Biosciences (ANIX) | 1991 | 113.33% |
Compass Therapeutics (CMPX) | 1991 | 78.95% |
Alkermes (ALKS) | 1991 | 75.61% |
Vertex Pharmaceuticals (VRTX) | 1991 | 63.89% |
Ionis Pharmaceuticals (IONS) | 1991 | 27.91% |
ImmuCell (ICCC) | 1991 | 22.22% |
XOMA (XOMA) | 1991 | 3.7% |
Lisata Therapeutics (LSTA) | 1991 | 0% |
Vera Therapeutics (VERA) | 1991 | -6.35% |
Eterna Therapeutics (ERNA) | 1991 | -16.67% |
Regeneron Pharmaceuticals (REGN) | 1991 | -17.61% |
Biogen (BIIB) | 1991 | -27.78% |
